For liver cancer. This could be the PI-88 killer. Consider your options before further price pressure makes the outlook for Progen very "sick" indeed.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025